price list

New GcMAF NEW GcMAF is produced using a patented process developed in Japan by Saisei Mirai, in collaboration with researchers from the University of Tokushima, who have been conducting GcMAF research for over 20 years. Manufactured in our sterile cell processing facility, this advanced formulation is 10–15 times more concentrated than conventional GcMAF and offers significantly enhanced stability and bioactivity. Clinically, this higher-concentration GcMAF has demonstrated a favorable safety profile, with the vast majority of patients experiencing no adverse effects. In rare cases (approximately 1 in 100), mild and transient symptoms such as low-grade fever or eczema may occur. Its improved resistance to oxidation contributes to greater stability, making NEW […]